{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:01:19Z","timestamp":1768881679247,"version":"3.49.0"},"reference-count":41,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/ol.2017.5872","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T04:03:54Z","timestamp":1489723434000},"page":"3579-3585","source":"Crossref","is-referenced-by-count":30,"title":["Angiotensin II receptor blockers induce autophagy in prostate cancer cells"],"prefix":"10.3892","volume":"13","author":[{"given":"Yunseo","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,17]]},"reference":[{"key":"key20180108113004_b1-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15265161.2013.807187","article-title":"Global aging and the allocation of health care across the life span","volume":"13","author":"Daniels","year":"2013","journal-title":"Am J Bioeth"},{"key":"key20180108113004_b2-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pon.1385","article-title":"Personality predicts prostate cancer treatment decision-making difficulty and satisfaction","volume":"18","author":"Orom","year":"2009","journal-title":"Psychooncology"},{"key":"key20180108113004_b3-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ajh.2008.313","article-title":"Hypertensive status and lipoprotein oxidation in an elderly population at high cardiovascular risk","volume":"22","author":"Guxens","year":"2009","journal-title":"Am J Hypertens"},{"key":"key20180108113004_b4-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2015.03.266","article-title":"Carvedilol use and specific cancer risk in the population with hypertension","volume":"186","author":"Lin","year":"2015","journal-title":"Int J Cardiol"},{"key":"key20180108113004_b5-ol-0-0-5872","first-page":"263","article-title":"Hypertension in cancer patients","volume":"38","author":"Mouhayar","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"key20180108113004_b6-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/iju.12273","article-title":"Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer","volume":"21","author":"Valcamonico","year":"2014","journal-title":"Int J Urol"},{"key":"key20180108113004_b7-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12032-012-0327-4","article-title":"Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients","volume":"30","author":"Tahover","year":"2013","journal-title":"Med Oncol"},{"key":"key20180108113004_b8-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/COC.0000000000000108","article-title":"Treatment-related hypertension as a pharmacodynamic biomarker for the efficacy of bevacizumab in advanced pancreas cancer: A pooled analysis of 4 prospective trials of gemcitabine-based therapy with bevacizumab","volume":"39","author":"Pant","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"key20180108113004_b9-ol-0-0-5872","first-page":"12656","article-title":"Angiotensin receptor blockers (ARBs) reduce the risk of lung cancer: A systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20180108113004_b10-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/07357907.2011.616252","article-title":"Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and\/or statins","volume":"29","author":"Chae","year":"2011","journal-title":"Cancer Invest"},{"key":"key20180108113004_b11-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jch.12225","article-title":"ACE inhibitors and ARBs: Do they reduce the risk of cancer?","volume":"16","author":"Mann","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key20180108113004_b12-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/468046a","article-title":"Structural biology: On stress and pressure","volume":"468","author":"Sigmund","year":"2010","journal-title":"Nature"},{"key":"key20180108113004_b13-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1368-5031.2006.00784.x","article-title":"Targeting effective blood pressure control with angiotensin receptor blockers","volume":"60","author":"Asmar","year":"2006","journal-title":"Int J Clin Pract"},{"key":"key20180108113004_b14-ol-0-0-5872","first-page":"381","article-title":"Angiotensin II receptor antagonists (AT1-blockers, ARBs, sartans): Similarities and differences","volume":"14","author":"van Zwieten","year":"2006","journal-title":"Neth Heart J"},{"key":"key20180108113004_b15-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/labinvest.3700504","article-title":"Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis","volume":"87","author":"Imai","year":"2007","journal-title":"Lab Invest"},{"key":"key20180108113004_b16-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"e35667","DOI":"10.1371\/journal.pone.0035667","article-title":"Angiotensin II facilitates breast cancer cell migration and metastasis","volume":"7","author":"Rodrigues-Ferreira","year":"2012","journal-title":"PLoS One"},{"key":"key20180108113004_b17-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1158\/1078-0432.CCR-05-2213","article-title":"Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer","volume":"12","author":"Kosugi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108113004_b18-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"745027","DOI":"10.1155\/2012\/745027","article-title":"A novel cellular model to study angiotensin II AT2 receptor function in breast cancer cells","volume":"2012","author":"Rodrigues-Ferreira","year":"2012","journal-title":"Int J Pept"},{"key":"key20180108113004_b19-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4161\/cbt.6.8.4412","article-title":"Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread","volume":"6","author":"Carl-McGrath","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"key20180108113004_b20-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/etm_00000046","article-title":"Telmisartan inhibits human urological cancer cell growth through early apoptosis","volume":"1","author":"Matsuyama","year":"2010","journal-title":"Exp Ther Med"},{"key":"key20180108113004_b21-ol-0-0-5872","first-page":"1139","article-title":"Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: A possibility of tyrosine kinase inhibitor of growth factor","volume":"2","author":"Uemura","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"key20180108113004_b22-ol-0-0-5872","first-page":"S155","article-title":"Role of renin-angiotensin system and antitumor effect of ARB in prostate cancer","volume":"69","author":"Uemura","year":"2011","journal-title":"Nihon Rinsho"},{"key":"key20180108113004_b23-ol-0-0-5872","first-page":"807","article-title":"Application of angiotensin II receptor blocker in prostate cancer","volume":"67","author":"Uemura","year":"2009","journal-title":"Nihon Rinsho"},{"key":"key20180108113004_b24-ol-0-0-5872","first-page":"295","article-title":"Telmisartan is a potent target for prevention and treatment in human prostate cancer","volume":"20","author":"Funao","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180108113004_b25-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2009.05.022","article-title":"The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis","volume":"138","author":"Burikhanov","year":"2009","journal-title":"Cell"},{"key":"key20180108113004_b26-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc1412","article-title":"Pathways of apoptotic and non-apoptotic death in tumour cells","volume":"4","author":"Okada","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180108113004_b27-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-385524-4.00002-7","article-title":"The essential role of evasion from cell death in cancer","volume":"111","author":"Kelly","year":"2011","journal-title":"Adv Cancer Res"},{"key":"key20180108113004_b28-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","article-title":"The role of autophagy in cancer development and response to therapy","volume":"5","author":"Kondo","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180108113004_b29-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","article-title":"Role of autophagy in cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180108113004_b30-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13258-010-0139-x","article-title":"Stimulation of the endosomal TLR pathway enhances autophagy-induced cell death in radiotherapy of breast cancer","volume":"32","author":"Kang","year":"2010","journal-title":"Genes & Genomics"},{"key":"key20180108113004_b31-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/pros.20980","article-title":"Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor","volume":"69","author":"Bose","year":"2009","journal-title":"Prostate"},{"key":"key20180108113004_b32-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/tera.1420070306","article-title":"The morphology of various types of cell death in prenatal tissues","volume":"7","author":"Schweichel","year":"1973","journal-title":"Teratology"},{"key":"key20180108113004_b33-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nrm2529","article-title":"Autophagic cell death: The story of a misnomer","volume":"9","author":"Kroemer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180108113004_b34-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1681\/ASN.2005080803","article-title":"Angiotensin II type 1 receptor-EGF receptor cross-talk regulates ureteric bud branching morphogenesis","volume":"17","author":"Yosypiv","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key20180108113004_b35-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jso.23184","article-title":"AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells","volume":"106","author":"Yang","year":"2012","journal-title":"J Surg Oncol"},{"key":"key20180108113004_b36-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/onc.2012.111","article-title":"The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells","volume":"32","author":"Galavotti","year":"2013","journal-title":"Oncogene"},{"key":"key20180108113004_b37-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"key":"key20180108113004_b38-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): A randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"key20180108113004_b39-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5414\/CPP48206","article-title":"Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease","volume":"48","author":"Abe","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key20180108113004_b40-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"key20180108113004_b41-ol-0-0-5872","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.112.248732","article-title":"Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis","volume":"32","author":"Yang","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2017.5872\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T10:43:19Z","timestamp":1515408199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.5872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,17]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,17]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/ol.2017.5872"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.5872","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,17]]}}}